AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 71 filers reported holding AEROVATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,644,410 | -20.9% | 1,963,479 | 0.0% | 0.15% | -21.0% |
| Q2 2023 | $33,673,665 | -15.0% | 1,963,479 | 0.0% | 0.20% | -9.3% |
| Q1 2023 | $39,603,371 | -31.6% | 1,963,479 | -0.7% | 0.22% | -38.2% |
| Q4 2022 | $57,922,232 | +76.5% | 1,976,868 | -0.1% | 0.35% | +61.9% |
| Q3 2022 | $32,821,000 | +1.4% | 1,979,568 | -4.4% | 0.22% | +16.8% |
| Q2 2022 | $32,354,000 | -14.7% | 2,070,010 | 0.0% | 0.18% | -15.6% |
| Q1 2022 | $37,943,000 | +75.7% | 2,070,010 | +13.0% | 0.22% | +107.6% |
| Q4 2021 | $21,597,000 | -37.7% | 1,831,789 | +10.9% | 0.10% | -30.9% |
| Q3 2021 | $34,663,000 | +6.3% | 1,652,171 | +15.7% | 0.15% | +6.3% |
| Q2 2021 | $32,614,000 | – | 1,428,571 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 3,758,686 | $78,857,000 | 4.67% |
| RA Capital Management | 8,263,982 | $173,378,000 | 2.40% |
| Cormorant Asset Management, LP | 2,030,691 | $41,962,000 | 1.70% |
| SECTORAL ASSET MANAGEMENT INC | 341,367 | $7,162,000 | 0.60% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 714,285 | $14,986,000 | 0.29% |
| Baker Brothers Advisors | 1,652,171 | $34,663,000 | 0.15% |
| Old Well Partners, LLC | 12,600 | $264,000 | 0.14% |
| Orbimed Advisors | 535,714 | $11,239,000 | 0.12% |
| Parkwood LLC | 48,059 | $1,008,000 | 0.12% |
| Darwin Global Management, Ltd. | 12,484 | $262,000 | 0.05% |